XOMA to Present at the Cowen and Company 40th Annual Health Care Conference
February 25, 2020 16:30 ET
|
XOMA Corporation
EMERYVILLE, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the Company’s business at...
XOMA Announces Closing of Rights Offering
December 20, 2019 16:35 ET
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced rights offering (the “Rights...
Iscalimab (CFZ533) Update
December 05, 2019 17:04 ET
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- As part of its R&D Day on December 5, 2019, Novartis highlighted the progress that has been made on iscalimab (CFZ533), a product candidate,...
XOMA Announces Commencement of Rights Offering
December 02, 2019 16:30 ET
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced the previously announced rights offering to raise...
XOMA Announces Proposed Rights Offering
November 19, 2019 16:30 ET
|
XOMA Corporation
Rights Offering will be available to all shareholders of record on November 29, 2019$22 million to be raised; fully backstopped EMERYVILLE, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- XOMA...
CORRECTING and REPLACING -- XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
November 05, 2019 10:59 ET
|
XOMA Corporation
EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by XOMA Corporation (Nasdaq: XOMA) please note that in the fifth paragraph of the...
XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
November 05, 2019 08:20 ET
|
XOMA Corporation
EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today reported its third quarter 2019 financial results. “XOMA’s portfolio of future potential royalty- and...
XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets
September 26, 2019 16:07 ET
|
XOMA Corporation
EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired a royalty interest in six clinical-stage assets targeting the adenosine...
XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 26, 2019 08:27 ET
|
XOMA Corporation
EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will provide a corporate update at the 2019 Cantor...
XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 03, 2019 08:00 ET
|
XOMA Corporation
EMERYVILLE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at...